This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP)
Pfizer asks US officials to OK promising COVID-19 pill
Nov 17, 2021 02:25:52 PM
Related news
-
Live updates | Ukraine's leader asks help in Grammys video -
Chinese, U.S. senior officials hold phone talks over trade -
EU signs new deal with Pfizer-BioNTech, Hungary opts out
-
Fed officials in April cautioned about inflation pressures
-
Chinese-built port in Kenya's Lamu to spur regional trade: offici -
Pfizer's posts $4.9B 1Q profit as vaccine strategy pays off
Top Stories
-
Chinese firms willing to invest more in EU if business environme Nov 06, 2020
-
Guangzhou's exhibition industry recovers from COVID-19 Nov 13, 2020
-
Tariffs for imports to be lowered next year Dec 27, 2020
-
China overtakes U.S. as world's top destination for FDI in 2020: Jan 26, 2021
-
Chinese vice premier stresses achieving higher-quality employment Feb 24, 2021
